// App-Quantinova.ai

55 : Baseline treatment patterns of the first 277 patients in PROMETCO: A real-world, prospective, longitudinal cohort study on the continuum of care in metastatic colorectal cancer (mCRC).

Researchers

Presenter

  • Jean-Baptiste Bachet

Principal Investigators

  • Carmine Pinto

  • Gyorgy Bodoky

  • Francisca Marti Marti

  • Andrey Mitroshkin

  • Marjolaine Fazilleau

  • Alice Vermeire

  • Ronan Fougeray

  • Rocio Garcia-Carbonero

  • Miriam Koopman

Medical Centers

  • Sorbonne Universites, Paris, France

  • Medical Oncology Unit, Clinical Cancer Center, AUSL-IRCCS Reggio Emilia, Reggio Emilia, Italy

  • St. Laszlo Teaching Hospital, Budapest, Hungary

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

  • Klinikum Freudenstadt, akademisches Lehrkrankenhaus der Universität Tübingen, Freudenstadt, Germany

  • Global Medical and Patient Affairs Servier, Suresnes, France

  • Global Medical Affairs Oncology, Servier, Suresnes, France

  • Institut de Recherches Internationales Servier, Suresnes, France

  • Hospital Universitario Doce de Octubre, Madrid, Spain

  • University Medical Center Utrecht, Utrecht, Netherlands

Locations

  • France

  • Italy

  • Hungary

  • United Kingdom

  • Germany

  • Spain

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

  • Microsatellite instability

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • N/A

Study Id's

  • NCT03935763

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved